This protocol is judged by an institutional overview board, an impartial group that critiques any clinical trials involving people. If a study will involve a Schedule I drug, once the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) amount from your FDA.Some researchers and businesses take